41 related articles for article (PubMed ID: 10765052)
1. Continuous facial myokymia in multiple sclerosis.
Clay JL; Villamar MF
Clin Case Rep; 2020 Nov; 8(11):2326-2327. PubMed ID: 33235796
[TBL] [Abstract][Full Text] [Related]
2. Facial Myokymia and Hemimasticatory Spasm with Linear Focal Alopecia.
Koneru V; Ondo WG
Mov Disord Clin Pract; 2023 Jan; 10(1):143-144. PubMed ID: 36988999
[No Abstract] [Full Text] [Related]
3. Eyelid myokymia caused by a trigeminal schwannoma as determined by the trigeminal-evoked blink reflex.
Ito E; Sugita R; Saito R
Clin Case Rep; 2023 Mar; 11(3):e7086. PubMed ID: 36937635
[TBL] [Abstract][Full Text] [Related]
4. Treatment of segmental continuous hypertrophic myokymia of the limb with botulinum A toxin.
Yousaf MIK; Ghani MR; D'Aguiar Rosa T; Holiday V; Brown M; Hedera P
SAGE Open Med Case Rep; 2022; 10():2050313X221137214. PubMed ID: 36406303
[TBL] [Abstract][Full Text] [Related]
5. Movement Disorders in Multiple Sclerosis: An Update.
Ghosh R; Roy D; Dubey S; Das S; Benito-León J
Tremor Other Hyperkinet Mov (N Y); 2022; 12():14. PubMed ID: 35601204
[TBL] [Abstract][Full Text] [Related]
6. Swallow-Induced Eyelid Myokymia: A Novel Synkinesis Syndrome.
Vuppala AD; Griepentrog GJ; Walsh RD
Neuroophthalmology; 2020 Apr; 44(2):108-110. PubMed ID: 32395158
[TBL] [Abstract][Full Text] [Related]
7. Botulinum Toxin Treatment of Movement Disorders.
Safarpour Y; Jabbari B
Curr Treat Options Neurol; 2018 Feb; 20(2):4. PubMed ID: 29478149
[TBL] [Abstract][Full Text] [Related]
8. Botulinum Toxin Treatment in Multiple Sclerosis-a Review.
Safarpour Y; Mousavi T; Jabbari B
Curr Treat Options Neurol; 2017 Aug; 19(10):33. PubMed ID: 28819801
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin in multiple sclerosis.
Jost WH
J Neurol; 2006 Feb; 253 Suppl 1():I16-20. PubMed ID: 16477480
[TBL] [Abstract][Full Text] [Related]
10. Use of botulinum toxin type A for the treatment of radiation therapy-induced myokymia and neuromyotonia in a dog.
Rogatko CP; Glass EN; Kent M; Hammond JJ; de Lahunta A
J Am Vet Med Assoc; 2016 Mar; 248(5):532-7. PubMed ID: 26885596
[TBL] [Abstract][Full Text] [Related]
11. Persistent facial myokymia: a rare pathognomic physical sign of intrinsic brain-stem lesions: report of 2 cases and review of literature.
Sharma RR; Mathad NV; Joshi DN; Mazarelo TB; Vaidya MM
J Postgrad Med; 1992; 38(1):37-40, 40A-40B. PubMed ID: 1512726
[TBL] [Abstract][Full Text] [Related]
12. Continuous facial myokymia in multiple sclerosis: treatment with botulinum toxin.
Sedano MJ; Trejo JM; Macarrón JL; Polo JM; Berciano J; Calleja J
Eur Neurol; 2000; 43(3):137-40. PubMed ID: 10765052
[TBL] [Abstract][Full Text] [Related]
13. Electromyographic guidance in injecting botulinum toxin.
Klein AW; Mantell A
Dermatol Surg; 1998 Nov; 24(11):1184-6. PubMed ID: 9834737
[TBL] [Abstract][Full Text] [Related]
14. [New techniques in maxillofacial surgery: local injection treatment with botulinum toxin A].
Roser M; Cornelius CP; Topka H
Mund Kiefer Gesichtschir; 1998 May; 2 Suppl 1():S121-4. PubMed ID: 9658837
[TBL] [Abstract][Full Text] [Related]
15. Dilution, storage, and electromyographic guidance in the use of botulinum toxins.
Mantell AM
Dermatol Clin; 2004 Apr; 22(2):135-6, v. PubMed ID: 15222572
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
